Skip to content

Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk

Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02832921
Enrollment
200
Registered
2016-07-14
Start date
2016-07-31
Completion date
2019-08-31
Last updated
2018-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease (AD)

Keywords

Alzheimer's disease, virtual reality, cognitive training

Brief summary

The primary objective of this program is to apply a virtual reality (VR) cognitive-motor intervention (compared to active and passive control groups) to delay or slow cognitive decline of middle-aged adults who have a family history of Alzheimer's disease (AD) and thus are at particularly high risk of developing the disease.

Interventions

BEHAVIORALcognitive training by virtual reality
BEHAVIORALwatching a scientific TV documentary
DEVICEtreadmill

VR cognitive training will be augmented by walking on a treadmill, since it is well established that dual tasking-i.e. performing the VR-based cognitive effort together with a motor task, even as simple as walking on a treadmill-places greater demand on cognitive resources than a single task.

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* The participants of the study must have at least one parent with Alzheimer's disease. * Fluency in Hebrew, in order to understand the instructions of the cognitive tests. * Availability of an informant for the participant.

Exclusion criteria

* Severe neurological or psychological conditions that may affect cognitive performance. * Substantial orthopedic limitations which prevent the use of treadmill. * Unstable medical condition such as an active cancer. * Incapability of adherence to the training program. * The participant is undergoing a treatment that may interfere with the study program.

Design outcomes

Primary

MeasureTime frameDescription
change in overall cognition- measured by averaging z-scores from 14 paper and pencil neuropsychological tests covering episodic memory and executive functions cognitive domains.baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)summary of the z-scores of all 14 paper and pencil cognitive tests
change in cerebral blood flow from arterial spin labeling (ASL)baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)acquired by structural MRI using background-suppressed pseudo-continuous ASL (pcASL) featuring a 3D fast spin echo spiral sequence

Secondary

MeasureTime frameDescription
brain resting state functional connectivity by resting state network fMRI BOLD signal correlationsbaseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)T2\*-weighted fMRI while relaxing with eyes closed; functional connectivity between seed regions of resting state networks (e.g., default mode, attentional, salience) and other regions by correlation of BOLD signal in seed regions with that in other regions
hippocampal volumebaseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)3D T1-weighted MRI imaging
specific cognitive domains- average of z-scores of paper and pencil memory tests and of executive functions testsbaseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)summary of z-scores of executive functions tests and of episodic memory tests
white matter hyperintensity (WMH) burdenbaseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)3D T2-FLAIR MRI imaging
diffusion-tensor imaging (DTI) measuresbaseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)diffusion-weighted MRI imaging (DWI) to map white matter tractography
frontal inferior cortex volumebaseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)3D T1-weighted MRI imaging
blood oxygenation level dependent (BOLD) functional MRI (fMRI) signal in the fronto-parietal network associated with working memorybaseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)T2\*-weighted fMRI during an n-back working memory task; contrasts: 1-back minus 0-back; 2-back minus 0-back; 2-back minus 1-back

Countries

Israel

Contacts

Primary ContactGlen M Doniger, PhD
Glen.Doniger@sheba.health.gov.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026